2016 Update and Progress: Acute Leukemia
Dr. Wendy Stock, professor of medicine, discusses targeted therapy for FLT3 mutant AML and novel approaches at The University of Chicago Medicine.
Published
September 1, 2016
Created by
Related Presenters
Anjuli Seth Nayak Professor in Leukemia
Wendy Stock, MD, is an authority in treating patients with all types of leukemia and myelodysplastic syndromes, including hematopoietic cell transplants. Her research efforts are directed to the design of clinical trials that tailor therapy ...